Healthcare provider profile · identity verified

Thomas M Burnette, MD

Internal Medicine · BREWSTER, NY · NPI 1609829878

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	538	174
Losartan Potassium	Losartan Potassium	480	130
Atorvastatin Calcium	Atorvastatin Calcium	456	134
Amlodipine Besylate	Amlodipine Besylate	415	109
Zolpidem Tartrate	Zolpidem Tartrate	225	33
Famotidine	Famotidine	194	58
Valsartan	Valsartan	186	55
Omeprazole	Omeprazole	146	40
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	135	20
Pravastatin Sodium	Pravastatin Sodium	134	42
Levothyroxine Sodium	Levothyroxine Sodium	125	32
Metoprolol Succinate	Metoprolol Succinate	123	39
Metformin Hcl Er	Metformin Hcl	113	36
Hydrochlorothiazide	Hydrochlorothiazide	111	31
Lisinopril	Lisinopril	109	31
Tamsulosin Hcl	Tamsulosin Hcl	109	29
Pantoprazole Sodium	Pantoprazole Sodium	107	31
Gabapentin	Gabapentin	104	37
Synthroid	Levothyroxine Sodium	102	27
Simvastatin	Simvastatin	97	27
Eliquis	Apixaban	96	20
Clonazepam	Clonazepam	94	27
Escitalopram Oxalate	Escitalopram Oxalate	93	29
Ezetimibe	Ezetimibe	93	29
Sertraline Hcl	Sertraline Hcl	92	25
Bupropion Xl	Bupropion Hcl	89	21
Allopurinol	Allopurinol	85	25
Spironolactone	Spironolactone	81	27
Montelukast Sodium	Montelukast Sodium	71	22
Potassium Chloride	Potassium Chloride	65	23
Tramadol Hcl	Tramadol Hcl	65	15
Alprazolam	Alprazolam	59	21
Eplerenone	Eplerenone	58	14
Fentanyl	Fentanyl	58	suppressed
Azithromycin	Azithromycin	57	46
Cefuroxime	Cefuroxime Axetil	57	26
Duloxetine Hcl	Duloxetine Hcl	55	15
Fluoxetine Hcl	Fluoxetine Hcl	55	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	53	14
Furosemide	Furosemide	50	16
Carvedilol	Carvedilol	49	15
Mounjaro	Tirzepatide	49	suppressed
Valacyclovir	Valacyclovir Hcl	49	28
Glimepiride	Glimepiride	46	14
Irbesartan	Irbesartan	46	12
Albuterol Sulfate Hfa	Albuterol Sulfate	45	27
Ipratropium Bromide	Ipratropium Bromide	44	13
Prednisone	Prednisone	41	25
Temazepam	Temazepam	40	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	40	14
Armour Thyroid	Thyroid,pork	38	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	38	29
Triamcinolone Acetonide	Triamcinolone Acetonide	38	26
Metformin Hcl	Metformin Hcl	37	suppressed
Trazodone Hcl	Trazodone Hcl	37	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	24
Ramipril	Ramipril	36	13
Lorazepam	Lorazepam	35	12
Metoprolol Tartrate	Metoprolol Tartrate	35	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	34	suppressed
Lovastatin	Lovastatin	32	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Celecoxib	Celecoxib	30	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	30	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	19
Zaleplon	Zaleplon	26	suppressed
Colchicine	Colchicine	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Atenolol	Atenolol	22	suppressed
Cefdinir	Cefdinir	22	17
Eszopiclone	Eszopiclone	22	suppressed
Ondansetron Odt	Ondansetron	22	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Diazepam	Diazepam	20	12
Jardiance	Empagliflozin	20	suppressed
Ozempic	Semaglutide	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Digoxin	Digoxin	18	suppressed
Lactulose	Lactulose	18	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Clopidogrel	Clopidogrel Bisulfate	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Tobramycin	Tobramycin	16	12
Propranolol Hcl	Propranolol Hcl	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Finasteride	Finasteride	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Methylprednisolone	Methylprednisolone	13	suppressed
Testosterone	Testosterone	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Fluticasone Propionate	Fluticasone Propionate	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Tramadol Hcl Er	Tramadol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error